Rahul Gupta is the nominee for Director of National Drug Control Policy, United States.
President Joe Biden on Tuesday (local time) announced his intent to nominate 11 individuals including two Indian-Americans to serve in key roles.
As per the White House statement, the nominated persons are - Gabe Camarillo, Alan Estevez, Jeff Lane Flake, Kent Doyle Logsdon, Lisa Wang, Chester John Culver, Rich Trumka Jr, James A Diossa, Terrence K Wright; with two Indian-Americans Rahul Gupta and Atul Gawande.
Rahul Gupta is the nominee for Director of National Drug Control Policy, while Atul Gawande is the nominee for Assistant Administrator of the Bureau for Global Health, United States Agency for International Development.
The son of an Indian diplomat, Rahul Gupta was born in India and grew up in the suburbs of Washington, D.C. He is a national and global thought leader and a driver of innovative public policies on health issues. Dr Gupta serves as an advisor to several organizations and task forces on local, national and international public health policy. He also led the development of the state's Zika action plan and its preparedness efforts during the Ebola Virus Disease Outbreak.
Atul Gawande is also founder and chair of Ariadne Labs, a joint center for health systems innovation at Brigham and Women's Hospital and the Harvard TH Chan School of Public Health, and of Lifebox, a nonprofit organization making surgery safer globally.
During the coronavirus pandemic, he co-founded CIC Health, which operates COVID-19 testing and vaccination nationally, and served as a member of the Biden transition COVID-19 Advisory Board.
In addition, Atul Gawande has been a staff writer for The New Yorker magazine since 1998 and written four New York Times best-selling books: Complications, Better, The Checklist Manifesto, and Being Mortal.